Feuerstein Tweet Shaved 16% From Targacept; Key Drug Fails Phase IIb Trial

By: via Benzinga
Shares of Targacept (NASDAQ: TRGT) fell as much as 16 percent Monday following a tweet from TheStreet.com's Adam ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.